Abstract
AbstractBACKGROUND: Magainin-AM2, a previously described amphibian host-defense peptide, stimulates insulin- and glucagon-like peptide-1-release in vitro. This study investigated anti-diabetic effects of the peptide in mice with diet-induced obesity and glucose intolerance.METHODS: Male National Institute of Health Swiss mice were maintained on a high-fat diet for 12-weeks prior to the daily treatment with magainin-AM2. Various indices of glucose tolerance were monitored together with insulin secretory responsiveness of islets at conclusion of study.RESULTS: Following twice daily treatment with magainin-AM2 for 15days, no significant difference in body weight and food intake was observed compared with saline-treated high fat control animals. However, non-fasting blood glucose was significantly (P
| Original language | English |
|---|---|
| Pages (from-to) | 80-87 |
| Journal | Biochim Biophys Acta |
| Volume | 1850 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published (in print/issue) - 20 Oct 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice.'. Together they form a unique fingerprint.Student theses
-
Metabolic and molecular characterization of novel insulinotropic peptides from skin secretions of frogs of the Pipidae family for the treatment of type 2 diabetes
Owolabi, B. O. (Author), Abdel-Wahab, Y. (Supervisor) & Flatt, P. (Supervisor), Dec 2015Student thesis: Doctoral Thesis
File
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver